SPHK1 and inflammatory bowel disease: The SphK1 inhibitor PF-543 had an inhibitory effect in a DSS-induced colitis mouse model, indicating that the SphK-S1P axis is closely associated with the progression of IBD (Liu and Jiang, 2020).